BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 23421851)

  • 1. Peyronie's disease and mechanotransduction: an in vitro analysis of the cellular changes to Peyronie's disease in a cell-culture strain system.
    Chung E; De Young L; Solomon M; Brock GB
    J Sex Med; 2013 May; 10(5):1259-67. PubMed ID: 23421851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Penile Traction and Vacuum Erectile Device for Peyronie's Disease in an Animal Model.
    Lin H; Liu C; Wang R
    J Sex Med; 2017 Oct; 14(10):1270-1276. PubMed ID: 28923308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes of RestoreX Penile Traction Therapy in Men With Peyronie's Disease: Results From Open Label and Follow-up Phases.
    Joseph J; Ziegelmann MJ; Alom M; Savage J; Köhler TS; Trost L
    J Sex Med; 2020 Dec; 17(12):2462-2471. PubMed ID: 33223425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute phase Peyronie's disease management with traction device: a nonrandomized prospective controlled trial with ultrasound correlation.
    Martínez-Salamanca JI; Egui A; Moncada I; Minaya J; Ballesteros CM; Del Portillo L; Sola I; Carballido J
    J Sex Med; 2014 Feb; 11(2):506-15. PubMed ID: 24261900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Penile traction therapy with the new device 'Penimaster PRO' is effective and safe in the stable phase of Peyronie's disease: a controlled multicentre study.
    Moncada I; Krishnappa P; Romero J; Torremade J; Fraile A; Martinez-Salamanca JI; Porst H; Levine L
    BJU Int; 2019 Apr; 123(4):694-702. PubMed ID: 30365247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Devices for penile traction: the long and winding road to treating Peyronie's disease.
    Setia SA; Levine LA
    Expert Rev Med Devices; 2018 Aug; 15(8):517-526. PubMed ID: 30016597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Penile Stretching as a Treatment for Peyronie's Disease: A Review.
    Cowper MG; Burkett CB; Le TV; Scherzer N; Hellstrom WJG
    Sex Med Rev; 2019 Jul; 7(3):508-515. PubMed ID: 30612978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Efficacy of Injection and Mechanical Therapy for Peyronie's Disease: A Systematic Review of the Literature.
    Russo GI; Milenkovic U; Hellstrom W; Levine LA; Ralph D; Albersen M
    Eur Urol; 2018 Dec; 74(6):767-781. PubMed ID: 30237020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Penile Traction Therapy and Vacuum Erection Devices in Peyronie's Disease.
    Avant RA; Ziegelmann M; Nehra A; Alom M; Kohler T; Trost L
    Sex Med Rev; 2019 Apr; 7(2):338-348. PubMed ID: 29631979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Basic fibroblast growth factor expression in Peyronie's disease.
    Mulhall JP; Thom J; Lubrano T; Shankey TV
    J Urol; 2001 Feb; 165(2):419-23. PubMed ID: 11176387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chromosomal instability is demonstrated by fibroblasts derived from the tunica of men with Peyronie's disease.
    Mulhall JP; Nicholson B; Pierpaoli S; Lubrano T; Shankey TV
    Int J Impot Res; 2004 Jun; 16(3):288-93. PubMed ID: 14961053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative Analysis of Tunical Plication vs. Intralesional Injection Therapy for Ventral Peyronie's Disease.
    Yafi FA; Hatzichristodoulou G; Knoedler CJ; Trost LW; Sikka SC; Hellstrom WJ
    J Sex Med; 2015 Dec; 12(12):2492-8. PubMed ID: 26646187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FastSize Medical Extender for the treatment of Peyronie's disease.
    Levine LA; Newell MM
    Expert Rev Med Devices; 2008 May; 5(3):305-10. PubMed ID: 18452379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Review of Management Options for Patients With Atypical Peyronie's Disease.
    Yafi FA; Hatzichristodoulou G; DeLay KJ; Hellstrom WJ
    Sex Med Rev; 2017 Apr; 5(2):211-221. PubMed ID: 27544298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiation increases fibrogenic cytokine expression by Peyronie's disease fibroblasts.
    Mulhall JP; Branch J; Lubrano T; Shankey TV
    J Urol; 2003 Jul; 170(1):281-4. PubMed ID: 12796706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of Peyronie's disease--a review.
    Tunuguntla HS
    World J Urol; 2001 Aug; 19(4):244-50. PubMed ID: 11550782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Application of traction therapy for Peyronie's disease: present and prospect].
    He ZH; Lu YP
    Zhonghua Nan Ke Xue; 2014 Jan; 20(1):78-82. PubMed ID: 24527543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination of penile traction, intralesional verapamil, and oral therapies for Peyronie's disease.
    Abern MR; Larsen S; Levine LA
    J Sex Med; 2012 Jan; 9(1):288-95. PubMed ID: 22024053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peyronie's disease fibroblasts demonstrate tumorigenicity in the severe combined immunodeficient (SCID) mouse model.
    Mulhall JP; Martin DJ; Lubrano T; Moser M; Kwon E; Wojcik E; Shankey TV
    Int J Impot Res; 2004 Apr; 16(2):99-104. PubMed ID: 14973530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A biomechanical model of Peyronie's disease.
    Gefen A; Chen J; Elad D
    J Biomech; 2000 Dec; 33(12):1739-44. PubMed ID: 11006403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.